Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Dec 28;35:103. doi: 10.1186/s40880-016-0167-2

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2016

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 2 — Survival curves of 749 patients with NPC who were treated with IMRT. The current 7th edition of the Union for International Cancer Control/American Joint Committee on Cancer (UICC/AJCC) staging system was used for staging. a The 5-year local relapse-free survival (LRFS) rates for patients with stage T1-T4 NPC were 98.4, 96.2, 93.0, and 90.5%, respectively. b The 5-year distant metastasis-free survival (DMFS) rates for patients with stage N0-N3b NPC were 93.3, 84.2, 72.4, 61.9, and 50.7%, respectively. c the 5-year overall survival (OS) rates for patients with stage I-IVb NPC were 97.4, 93.8, 81.8, 69.7, and 54.0%, respectively